This trial is conducted in Asia, South America and the United States of America (USA).
The aim of this clinical trial is to determine whether two insulin treatments given once
daily are equally effective with respect to the blood glucose lowering effect in subjects
with type 2 diabetes inadequately controlled on metformin treatment with or without an
additional anti-diabetic drug (OAD).